Cryo Cell International (CCEL) Cost of Revenue (2010 - 2026)

Cryo Cell International (CCEL) has 17 years of Cost of Revenue data on file, last reported at $1.7 million in Q1 2026.

• Cost of Revenue for Q1 2026 came in at $1.7 million, down 16.53% year-over-year; the trailing twelve-month figure through Feb 2026 was $7.0 million (down 9.31% YoY), and the FY2025 annual result was $7.4 million, down 7.19% from the prior year.
• Cost of Revenue slipped to $1.7 million in Q1 2026 per CCEL's latest filing, from $1.7 million in the prior quarter.
• Over five years, Cost of Revenue peaked at $2.3 million in Q3 2022 and troughed at $1.6 million in Q4 2024.
• A 5-year average of $2.0 million and a median of $2.1 million in 2024 frame the typical range for Cost of Revenue.
• The sharpest annual moves came in 2024 and 2025: Cost of Revenue decreased 19.13% in 2024, then increased 5.95% in 2025.
• A 5-year view of Cost of Revenue shows it stood at $2.1 million in 2022, then declined by 5.38% to $2.0 million in 2023, then declined by 19.13% to $1.6 million in 2024, then rose by 5.95% to $1.7 million in 2025, then fell by 4.48% to $1.7 million in 2026.
• Business Quant data shows CCEL's Cost of Revenue at $1.7 million in Q1 2026, $1.7 million in Q4 2025, and $1.8 million in Q3 2025.